Enteroinvasive Escherichia coli (EIEC) comprises those E. coli strains that possess a high-molecular-weight virulence plasmid closely related to the virulence plasmid of shigellae (7) . As a result, EIEC produces shigellalike, virulence-associated polypeptides and is capable of causing shigellalike invasive diarrhea (6, 13) . A 17-kilobase EcoRI fragment of the virulence plasmid that has been shown to be essential for invasiveness (12) has been used to probe E. coli strains for this plasmid (16) . We have recently shown that shigellae differ in the types and amounts of cytotoxins they produce. Shigella dysenteriae 1 is consistently a high-level Shiga toxin producer, while other shigellae produce little or no Shiga toxin (1) . However, these other shigellae do produce low levels of a second cytotoxin not immunologically related to Shiga toxin. Shiga toxin is thought to be an important virulence determinant, which may account for the severity typical of S. dysenteriae 1 as well as for involvement of Shiga toxin in the pathogenesis of the S. dysenteriae 1-associated hemolytic uremic syndrome. Some E. coli strains make related toxins. Those strains that produce a cytotoxin neutralizable with antibody to Shiga toxin are said to make Shiga-like toxin I (SLT-I). Many strains of E. coli are high-level producers of a second cytotoxin (referred to as SLT-II) closely related to Shiga toxin but not neutralizable with antibody to Shiga toxin. Numerous serotypes of E. coli are now recognized as producers of either SLT-I or SLT-II or both. The most important of these serotypes are E. coli 0157:H7 and E. coli 026:H11. There has been little investigation of EIEC strains to determine whether they produce shigellalike cytotoxins as well as possessing the shigella virulence plasmid. The purpose of this study was, therefore, to analyze all the usual EIEC serotypes from several different geographic regions to determine their capacities for cytotoxin production.
Bacterial strains. A total of 10 EIEC strains isolated from Thai patients and 9 EIEC strains from Vietnamese patients were obtained from Peter Echeverria. In addition, 10 strains of EIEC isolated from U.S. travelers to Guadalajara, Mexico, were obtained from Herbert DuPont. One EIEC strain associated with a foodborne outbreak of disease in Houston was provided by Gordon Reeve. For purposes of comparison, we chose, at random, colonies of E. coli from 3 patients who had traveler's diarrhea in Mexico and 10 well patients. These colonies of E. coli were analyzed for cytotoxin production. The enterotoxigenic strain H10407 was included * Corresponding author.
as a negative control, since it is known to be SLT-I and SLT-II negative. S. dysenteriae 1-60R and E. coli C600 (933W) were included as positive controls for SLT-I and SLT-II, respectively.
Virulence plasmid analysis. Lysates of each strain were prepared by the method of Kado and Liu (8) . These lysates were then electrophoresed in 0.7% horizontal agarose gels, stained with ethidium bromide, and photographed under UV-light illumination. The sizes of plasmids were determined by using known molecular size standards.
Virulence probe analysis. The DNA probe used (5, 16) for these studies was the 17-kilobase EcoRI fragment originally isolated from the invasiveness plasmid of Shigella flexneri serotype 5 (2). The probe was isolated, nick translated with [a-32P]dATP, and hybridized under conditions of high stringency (42°C in 50% formamide) (10) with filters containing colony lysates.
Cytotoxin characterization. Each strain was grown in irondepleted syncase broth, sonicated, filter sterilized, and serially diluted in 96-well plates containing Eagle minimal essential medium and Earle saîts (Hazleton Dutchland, Denver, Pa.), 10% fetal calf serum, and 2 mM L-glutamine and thymidine (2 ,uCi/ml; ICN Radiochemicals, Irvine, Calif.). HeLa cells (-50,000 cells per well) were added at the same time as the sonic extracts, incubated overnight at 37°C, washed to remove unattached cells and unincorporated label, lysed with 1 N KOH, and counted in a 13-scintillation counter. The dilution of toxin that killed 50% of HeLa cells (CD5dml) was calculated and corrected for protein concentration (CD5_mg) as described previously (4) . Characterization of cytotoxin type (SLT-I, SLT-II, or nonneutralizable cytotoxin) was determined by using polyclonal rabbit antiserum to Shiga toxin prepared from S. dysenteriae 1-60R and rabbit antiserum to E. coli C600 (933W) kindly provided by A. D. O'Brien. Appropriate controls were used to ensure that the antibody dilutions used were adequate to neutralize each of the respective toxins. Each strain was assayed at least twice. Table 1 lists the sources of EIEC strains and their serotypes, as well as their plasmid, probe, and cytotoxin characterizations. All EIEC strains contained large plasmids (120 to 140 megadaltons) that hybridized with the 17-kilobase probe for the invasiveness genes. Each EIEC strain had a different total plasmid profile, except for the four E. coli 0143:H-strains isolated in Mexico, which were identical to each other (A. Wanger, submitted for publication). Strain H10407, 3 diarrhea-associated fecal E. coli isolates, and 10 J. CLIN. MICROBIOL. E. coli isolates from the feces of 10 well persons were also studied. As expected, E. coli isolates that were probe negative were also plasmid negative. Each EIEC strain produced low levels of cytotoxic activity. Levels of cytotoxin produced were 100-to 1,000-fold lower than those produced by S. dysenteriae 1-60R. The levels of nonneutralized cytotoxic activity were not different from those found in other E. coli strains or in shigellae other than S. dysenteriae serotype 1 (1, 4). There was no significant difference in the amount of cytotoxin produced by one serotype compared with that produced by the others, nor was there a significant difference in the amount of cytotoxic activity produced by strains isolated in different geographic regions. In no case was the cytotoxicity neutralized by antibody against SLT-I or SLT-II.
Studied here are typical EIEC strains representing all of the recognized EIEC serogroups. They were all well characterized in terms of serotypes, plasmids, and probes. Previous data on EIEC cytotoxin production is scant. The original description, by O'Brien et al., of Shiga-like cytotoxin production by E. coli included a single EIEC strain (14) . That strain (E. coli 0143 strain 4608-58-899) was said to produce 40 CD50 of SLT-I per mg of bacterial protein.
Although this is the same range of total cytotoxin production we found, none of our isolates produced a neutralizable toxin. Since seven of our strains were E. coli 0143 and none of them produced detectable Shiga-like toxins, we suspect that such toxin production by these strains is very uncommon. The same investigators have reported nine human EIEC isolates of undefined serotype that were low-level producers of nonneutralizable cytotoxin (11) . The current study clearly demonstrates that all common EIEC serotypes are low-level cytotoxin producers. The toxin these strains produce is unrelated immunologically to SLT-I or SLT-II. Our data are consistent with those of Smith et al., who demonstrated that the genes for toxin production were absent in several EIEC isolates that they analyzed by toxin probes (17) . That all of the recognized serotypes of EIEC were evaluated is particularly important because for both E. coli and shigellae, serotype correlates well with the type of cytotoxin produced (9) . That is, all E. coli 0157:H7 are high-level SLT-I or SLT-II producers, while S. dysenteriae 1 is predictably a high-level Shiga toxin producer (1, 11 1. This study demonstrated that EIEC strains are also unlike S. dysenteriae 1 in toxin production. The significance of low-level cytotoxin production is uncertain. The amounts of nonneutralizable cytotoxin produced by EIEC were not different from those produced by the other E. coli and shigellae that were examined. Likewise, the levels are in the same range as those previously reported for other fecal E. coli (4, 11) . That none of the serotypes of EIEC was found to produce either SLT-I or SLT-II is good evidence that these toxins are not involved in the pathogenesis of EIEC disease. From this evidence follows the prediction that as more E. coli that are associated with hemolytic uremic syndrome and hemorrhagic colitis are defined, EIEC will be found not to be associated with these illnesses.
